Infosys Limited vs McKesson Corporation — how do they compare? Infosys Limited trades at $11.18 (market cap $46.65B), while McKesson Corporation trades at $832.45 (market cap $97.35B). The key difference: McKesson Corporation is far larger — about 2.1× Infosys Limited's market cap, and Infosys Limited pays the higher dividend (4.63%). Which is the better fit depends on your goals.
| INFY | MCK | |
|---|---|---|
Market Cap | $46.65B | $97.35B |
Sector | Technology | Health |
52-Week High | $20.22 | $995.69 |
52-Week Low | $10.49 | $659.01 |
Enterprise Value | $43.87B | $101.98B |
Dividend Yield | 4.63% | 0.39% |
Trailing returns across standard periods
Infosys is a global leader in next-generation digital services and consulting. It enables clients in more than 50 countries to navigate their digital transformation through AI-powered cloud and data solutions.
Read more on INFY →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →